Shares of Ocugen Inc. (NAS:OCGN) slipped 5.90% to $8.30 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index (S&P:SPX) falling 0.00% to 4,682.80 and Dow Jones Industrial Average (DOW:DJIA) falling 0.04% to 36,087.45. The stock's fall snapped a two-day winning streak. Ocugen Inc. closed $10.47 below its 52-week high ($18.77), which the company achieved on February 8th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Adverum Biotechnologies Inc. (NAS:ADVM) fell 1.36% to $2.17, Ocular Therapeutix Inc. (NAS:OCUL) rose 1.58% to $7.08, and Kodiak Sciences Inc. (NAS:KOD) fell 6.90% to $104.58. Trading volume (11.6 M) remained 26.1 million below its 50-day average volume of 37.7 M.